CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-07 | Neervannan Seshadri Chief Operating Officer | Grant or award · Restricted Stock Units | +32,079 | 32,079 | ||
| 2024-01-25 | Lin Elizabeth Yeu Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-12-27 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −8,000 | $20.22 | $162K | 830,106 |
| 2023-12-20 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −9,443 | $19.96 | $188K | 868,663 |
| 2023-12-20 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −30,557 | $20.36 | $622K | 838,106 |
| 2023-12-20 | Trevejo Jose M. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,252 | $20.00 | $45K | 2,251 |
| 2023-12-15 | Goldberg Andrew D. Director | Purchase | +1,000 | $18.96 | $19K | 3,000 |
| 2023-12-02 | YARNO WENDY L Director | Exercise or conversion | +5,000 | 7,000 | ||
| 2023-12-02 | YARNO WENDY L Director | Exercise or conversion · Restricted Stock Units | −5,000 | 0 | ||
| 2023-11-30 | Wahl Bryan General Counsel | Sale | −8,356 | $16.31 | $136K | 31,966 |
| 2023-11-30 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −8,355 | $16.31 | $136K | 26,784 |
| 2023-11-29 | Wahl Bryan General Counsel | Exercise or conversion | +23,920 | 40,322 | ||
| 2023-11-29 | Wahl Bryan General Counsel | Exercise or conversion · Restricted Stock Units | −23,920 | 0 | ||
| 2023-11-29 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion | +23,920 | 35,139 | ||
| 2023-11-29 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion · Restricted Stock Units | −23,920 | 0 | ||
| 2023-11-15 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −2,896 | $18.01 | $52K | 883,210 |
| 2023-11-15 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −4,904 | $18.54 | $91K | 878,306 |
| 2023-11-15 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −200 | $19.28 | $4K | 878,106 |
| 2023-10-18 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −8,000 | $13.24 | $106K | 886,106 |
| 2023-10-05 | Trevejo Jose M. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,604 | $18.00 | $29K | 4,503 |
Page 17 of 24 · 469 trades